| 2013 ESH/ESC Guidelines for the management of arterial hypertension G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ... Arterial Hypertension 17 (2), 69-168, 2013 | 27119* | 2013 |
| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 14564 | 2018 |
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … European Journal of Preventive Cardiology 19 (4), 585-667, 2012 | 7144 | 2012 |
| Telmisartan, ramipril, or both in patients at high risk for vascular events Ontarget Investigators New England Journal of Medicine 358 (15), 1547-1559, 2008 | 4936 | 2008 |
| Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of … L Rydén, E Standl, M Bartnik, G Van den Berghe, J Betteridge, ... European heart journal 28 (1), 88-136, 2007 | 2131 | 2007 |
| Cardiorenal end points in a trial of aliskiren for type 2 diabetes HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ... New England Journal of Medicine 367 (23), 2204-2213, 2012 | 1641 | 2012 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1228 | 2008 |
| Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ... European heart journal 41 (22), 2083-2088, 2020 | 1030 | 2020 |
| Thrombin-receptor antagonist vorapaxar in acute coronary syndromes P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ... New England Journal of Medicine 366 (1), 20-33, 2012 | 905 | 2012 |
| Valsartan for prevention of recurrent atrial fibrillation GISSI-AF Investigators New England Journal of Medicine 360 (16), 1606-1617, 2009 | 603 | 2009 |
| High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species F Cosentino, M Eto, P De Paolis, B van der Loo, M Bachschmid, V Ullrich, ... Circulation 107 (7), 1017-1023, 2003 | 603 | 2003 |
| Expert consensus document from the European Society of Cardiology on catheter-based renal denervation F Mahfoud, TF Lüscher, B Andersson, I Baumgartner, R Cifkova, ... European Heart Journal 34 (28), 2149-2157, 2013 | 568 | 2013 |
| Acute anti-ischemic effect of testosterone in men with coronary artery disease GMC Rosano, F Leonardo, P Pagnotta, F Pelliccia, G Panina, ... Circulation 99 (13), 1666-1670, 1999 | 552 | 1999 |
| Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ... Annals of internal medicine 163 (1), 40-51, 2015 | 551 | 2015 |
| Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension G Iaccarino, G Grassi, C Borghi, C Ferri, M Salvetti, M Volpe Hypertension 76 (2), 366-372, 2020 | 451 | 2020 |
| Mammalian target of rapamycin signaling in cardiac physiology and disease S Sciarretta, M Volpe, J Sadoshima Circulation research 114 (3), 549-564, 2014 | 435 | 2014 |
| Current situation of medication adherence in hypertension B Vrijens, S Antoniou, M Burnier, A De la Sierra, M Volpe Frontiers in pharmacology 8, 100, 2017 | 365 | 2017 |
| The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment M Volpe, M Carnovali, V Mastromarino Clinical Science 130 (2), 57-77, 2016 | 347 | 2016 |
| Insulin-like growth factor-1 as a vascular protective factor E Conti, C Carrozza, E Capoluongo, M Volpe, F Crea, C Zuppi, ... Circulation 110 (15), 2260-2265, 2004 | 326 | 2004 |
| Natriuretic peptides in cardiovascular diseases: current use and perspectives M Volpe, S Rubattu, J Burnett Jr European heart journal 35 (7), 419-425, 2014 | 318 | 2014 |
